Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Richter

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2017
Targeted Exome Sequencing of Krebs Cycle Genes Reveals Candidate Cancer-Predisposing Mutations in Pheochromocytomas and ParagangliomasLaura Remacha, Iñaki Comino-Méndez, Susan Richter, et al.
International Journal of Cancer|March 29, 2014
Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor XNan Qin, Aguirre A de Cubas, Ruben Garcia-Martin, et al.
Endocrine-Related Cancer|February 16, 2022
Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramineSusan Richter, Bei Qiu, Mirthe Ghering, et al.
Cell Reports|February 23, 2022
Cellular plasticity upon proton irradiation determines tumor cell radiosensitivityIñaki Schniewind, Wahyu Wijaya Hadiwikarta, Julia Grajek, et al.
Journal of the Endocrine Society|April 17, 2026
Clinical and genetic characteristics of head and neck paragangliomas from China featuring Sino-European comparisonsJun Liu, Yingxian Pang, Jianing Yue, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 28, 2018
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paragangliomaSusan Richter, Laura Gieldon, Ying Pang, et al.
Cancers|June 20, 2019
Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research ApproachesLaura Gieldon, Doreen William, Karl Hackmann, et al.
Cancers|January 1, 2020
Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor OriginJulia Biedermann, Matthias Preussler, Marina Conde, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2022
Somatic IDH1 Hotspot Variants in Chinese Patients With Pheochromocytomas and ParagangliomasMinghao Li, Yazhi He, Yingxian Pang, et al.
Frontiers in Endocrinology|March 29, 2021
Succinate Mediates Tumorigenic Effects <i>via</i> Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient ParagangliomasDieter M Matlac, Katerina Hadrava Vanova, Nicole Bechmann, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2017
Targeted Exome Sequencing of Krebs Cycle Genes Reveals Candidate Cancer-Predisposing Mutations in Pheochromocytomas and ParagangliomasLaura Remacha, Iñaki Comino-Méndez, Susan Richter, et al.
International Journal of Cancer|March 29, 2014
Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor XNan Qin, Aguirre A de Cubas, Ruben Garcia-Martin, et al.
Endocrine-Related Cancer|February 16, 2022
Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramineSusan Richter, Bei Qiu, Mirthe Ghering, et al.
Cell Reports|February 23, 2022
Cellular plasticity upon proton irradiation determines tumor cell radiosensitivityIñaki Schniewind, Wahyu Wijaya Hadiwikarta, Julia Grajek, et al.
Journal of the Endocrine Society|April 17, 2026
Clinical and genetic characteristics of head and neck paragangliomas from China featuring Sino-European comparisonsJun Liu, Yingxian Pang, Jianing Yue, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 28, 2018
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paragangliomaSusan Richter, Laura Gieldon, Ying Pang, et al.
Cancers|June 20, 2019
Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research ApproachesLaura Gieldon, Doreen William, Karl Hackmann, et al.
Cancers|January 1, 2020
Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor OriginJulia Biedermann, Matthias Preussler, Marina Conde, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2022
Somatic IDH1 Hotspot Variants in Chinese Patients With Pheochromocytomas and ParagangliomasMinghao Li, Yazhi He, Yingxian Pang, et al.
Frontiers in Endocrinology|March 29, 2021
Succinate Mediates Tumorigenic Effects <i>via</i> Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient ParagangliomasDieter M Matlac, Katerina Hadrava Vanova, Nicole Bechmann, et al.
Pageof 9